DYNATRONICS CORP (DYNT)

US2681575005 - Common Stock

0.5312  -0.02 (-4.27%)

After market: 0.5137 -0.02 (-3.29%)

Fundamental Rating

1

DYNT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. DYNT has a bad profitability rating. Also its financial health evaluation is rather negative. DYNT has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year DYNT has reported negative net income.
DYNT had a negative operating cash flow in the past year.
DYNT had negative earnings in 4 of the past 5 years.
Of the past 5 years DYNT 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -19.46%, DYNT is in line with its industry, outperforming 54.69% of the companies in the same industry.
The Return On Equity of DYNT (-36.72%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -19.46%
ROE -36.72%
ROIC N/A
ROA(3y)-9.7%
ROA(5y)-8.98%
ROE(3y)-16.87%
ROE(5y)-16.12%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of DYNT (21.55%) is worse than 79.17% of its industry peers.
DYNT's Gross Margin has declined in the last couple of years.
DYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.02%
GM growth 5Y-4.64%

1

2. Health

2.1 Basic Checks

DYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DYNT has more shares outstanding
DYNT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DYNT is higher compared to a year ago.

2.2 Solvency

DYNT has an Altman-Z score of -0.37. This is a bad value and indicates that DYNT is not financially healthy and even has some risk of bankruptcy.
DYNT has a Altman-Z score (-0.37) which is comparable to the rest of the industry.
DYNT has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
DYNT has a Debt to Equity ratio (0.22) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -0.37
ROIC/WACCN/A
WACC11.44%

2.3 Liquidity

A Current Ratio of 1.41 indicates that DYNT should not have too much problems paying its short term obligations.
DYNT has a Current ratio of 1.41. This is amonst the worse of the industry: DYNT underperforms 84.38% of its industry peers.
A Quick Ratio of 0.67 indicates that DYNT may have some problems paying its short term obligations.
With a Quick ratio value of 0.67, DYNT is not doing good in the industry: 94.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.67

2

3. Growth

3.1 Past

DYNT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.82%.
DYNT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.83%.
DYNT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.81% yearly.
EPS 1Y (TTM)2.82%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)-20.83%
Revenue growth 3Y-8.73%
Revenue growth 5Y-8.81%
Revenue growth Q2Q-25.08%

3.2 Future

Based on estimates for the next years, DYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 31.97% on average per year.
The Revenue is expected to decrease by -3.17% on average over the next years.
EPS Next Y35.73%
EPS Next 2Y31.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.58%
Revenue Next 2Y-3.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYNT. In the last year negative earnings were reported.
Also next year DYNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as DYNT's earnings are expected to grow with 31.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.97%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DYNT!.
Industry RankSector Rank
Dividend Yield N/A

DYNATRONICS CORP

NASDAQ:DYNT (4/29/2024, 7:00:01 PM)

After market: 0.5137 -0.02 (-3.29%)

0.5312

-0.02 (-4.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.59M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.46%
ROE -36.72%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 21.55%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.41
Quick Ratio 0.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)2.82%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y35.73%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-20.83%
Revenue growth 3Y-8.73%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y